Mucomyst Related Published Studies
Well-designed clinical trials related to Mucomyst (Acetylcysteine Inhalation)
Meta-analysis of N-Acetylcysteine to Prevent Acute Renal Failure After Major Surgery. [2008.07.21]
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. [2008.06.06]
Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. [2008.06.01]
Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. [2008.06]
N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. [2008.05]
N-Acetylcysteine does not artifactually lower plasma creatinine concentration. [2008.05]
Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. [2008.05]
Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results. [2008.04]
Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. [2008.01]
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. [2008.01]
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. [2007.12]
N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. [2007.11]
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial* [2007.10.16]
Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. [2007.10]
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. [2007.09]
I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. [2007.09]
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect. [2007.09]
Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. [2007.09]
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. [2007.08]
Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans. [2007.08]
Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. [2007.05]
Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. [2007.05]
The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. [2007.03.27]
Randomized, double-blind, placebo-controlled trial of Intravenous (n-acetylcysteine, selenium, vitamin c) Antioxidant therapy in severe acute pancreatitis. [2007.03.13]
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy : The Dialysis-versus-Diuresis (DVD) Trial. [2007.03]
Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. [2007.01.31]
Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. [2007.01]
Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. [2007]
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy : The Dialysis-versus-Diuresis (DVD) Trial. [2006.12.22]
Effects of acetylcysteine and ischaemic preconditioning on muscular function and postoperative pain after orthopaedic surgery using a pneumatic tourniquet. [2006.12]
Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. [2006.11]
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. [2006.11]
Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. [2006.10.18]
N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans. [2006.10.01]
Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study. [2006.10]
The role of N-acetylcysteine in lower extremity ischemia/reperfusions. [2006.10]
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe? [2006.09]
Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. [2006.07]
Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. [2006.07]
N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. [2006.06.29]
N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. [2006.06.21]
N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. [2006.06]
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. [2006.06]
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). [2006.05.24]
Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. [2006.05]
The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity. [2006.05]
N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. [2006.05]
Efficacy of the antioxidant N-acetylcysteine (NAC) in protecting ears exposed to loud music. [2006.04]
Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. [2006.02]
The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. [2006.01]
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. [2006.01]
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. [2006.01]
Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease. [2006]
High-dose acetylcysteine in idiopathic pulmonary fibrosis. [2005.11.24]
A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis. [2005.09]
Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. [2005.08]
Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. [2005.07.20]
N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. [2005.06]
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. [2005.04.30]
Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study. [2005.04]
The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. [2005.04]
[Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis] [2005.03.18]
Effectiveness of acetylcysteine in prevention of contrast nephropathy. [2005.02]
Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. [2005]
Well-designed clinical trials possibly related to Mucomyst (Acetylcysteine Inhalation)
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. [2008.09.15]
Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. [2008.08.19]
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. [2008.08]
Elesclomol induces cancer cell apoptosis through oxidative stress. [2008.08]
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. [2008.08]
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study. [2008.05.14]
Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. [2008.03]
The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism. [2008.01]
Effect of cysteine derivatives administration in healthy men exposed to intense resistance exercise by evaluation of pro-antioxidant ratio. [2007.12]
High altitude induced anorexia: effect of changes in leptin and oxidative stress levels. [2007.10]
N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. [2007.09.15]
Cardiovascular disease in patients with chronic kidney disease. A clinical review. [2007.09]
Prevention of contrast-induced nephropathy in vascular surgery patients. [2007.09]
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. [2007.08]
Influence of cabbage processing methods and prebiotic manipulation of colonic microflora on glucosinolate breakdown in man. [2007.08]
N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. [2007.08]
Prevention of contrast-induced nephropathy: a critical review. [2007.07]
A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). [2007.07]
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. [2007.06.26]
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis> [2007.05.04]
Effect of meal composition and cooking duration on the fate of sulforaphane following consumption of broccoli by healthy human subjects. [2007.04]
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. [2007.03.13]
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease. [2007.01.24]
Modification of cardiovascular risk in hemodialysis patients: An evidence-based review. [2007.01]
N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. [2007]
New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid. [2006.11]
Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. [2006.09]
The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. [2006.07]
Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. [2006.01]
Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures--a randomised controlled trial. [2005.12]
Quality control of spirometry: a lesson from the BRONCUS trial. [2005.12]
[Efficacy of Derinox(R) Assessed with One PNIF (Peak Nasal Inspiratory Flow) in Patients Suffering from Common Cold.] [2005.11]
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: A single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. [2005.11]
Effect of low-dose N-acetyl-cysteine infusion on tourniquet-induced ischaemia-reperfusion injury in arthroscopic knee surgery. [2005.07]
Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial. [2005.05.14]
A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation. [2005.04]
Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients? [2005.04]
|
